)
BridgeBio Oncology Therapeutics (BBOT) investor relations material
BridgeBio Oncology Therapeutics Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Annual meeting scheduled for June 16, 2026, with virtual participation available for shareholders.
Shareholders are encouraged to review proxy materials and annual report before voting.
Voting matters and shareholder proposals
Election of two Class I directors, Frank McCormick and Peter Lebowitz, to serve until the 2029 annual meeting.
Ratification of Deloitte & Touche LLP as independent registered public accounting firm for fiscal year ending December 31, 2026.
Provision to transact any other business properly brought before the meeting or its adjournment.
Board of directors and corporate governance
Board recommends voting in favor of both director nominees and the auditor ratification.
- Election of directors and auditor ratification, with strong governance and independent oversight.BBOT
Proxy filing28 Apr 2026 - KRAS-targeted therapies show high efficacy, safety, and promise for underserved cancer populations.BBOT
44th Annual J.P. Morgan Healthcare Conference16 Apr 2026 - Three RAS-pathway inhibitors show strong efficacy and safety, with major updates due in 2026.BBOT
Study Update12 Apr 2026 - Three next-gen RAS therapeutics show promising efficacy and safety, with key data due in 2026.BBOT
Leerink Global Healthcare Conference 202610 Mar 2026 - Advanced three RAS-pathway inhibitors with strong cash runway and key data readouts expected in 2026.BBOT
Q4 20255 Mar 2026 - Novel RAS-targeted therapies show strong efficacy and safety, with major data readouts expected soon.BBOT
Oppenheimer 36th Annual Healthcare Life Sciences Conference25 Feb 2026 - All three oncology programs progressed in 2025, with major data readouts and strategic decisions set for 2026.BBOT
Evercore ISI 8th Annual HealthCONx Conference3 Dec 2025 - Advancing three novel oncology assets with strong early data and robust funding through 2028.BBOT
Piper Sandler 37th Annual Healthcare Conference3 Dec 2025 - IPO covers 63M shares for resale; biotech targets RAS/PI3Kα cancers, faces high risk.BBOT
Registration Filing29 Nov 2025
Next BridgeBio Oncology Therapeutics earnings date
Next BridgeBio Oncology Therapeutics earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
Frequently asked questions
Explore our global coverage